ENTRY       D02829                      Drug
NAME        Alosetron hydrochloride (USAN);
            Lotrpnex (TN)
PRODUCT     LOTRONEX (Sebela Pharmaceuticals)
  GENERIC   ALOSETRON (Bryant Ranch Prepack)
            ALOSETRON (Bryant Ranch Prepack)
            ALOSETRON (Lifestar Pharma LLC)
            ALOSETRON HYDROCHLORIDE (Actavis Pharma)
            ALOSETRON HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            ALOSETRON HYDROCHLORIDE (Rising Pharmaceuticals)
            ALOSETRON HYDROCHLORIDE (West-Ward Pharmaceuticals Corp.)
FORMULA     C17H18N4O. HCl
EXACT_MASS  330.1247
MOL_WEIGHT  330.812
CLASS       Gastrointestinal agent
             DG01489  5-HT3-receptor antagonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01642  CYP2C9 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: A03AE01
            Chemical structure group: DG00046
            Product (DG00046): D02829<US>
EFFICACY    Anti-emetic, Serotonin 5-HT3 receptor antagonist
  DISEASE   Irritable bowel syndrome [DS:H01615]
TARGET      HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]
  PATHWAY   hsa04726(170572+200909+285242+3359+9177)  Serotonergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544]; CYP3A4 [HSA:1576], CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
               A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
                A03AE Serotonin receptor antagonists
                 A03AE01 Alosetron
                  D02829  Alosetron hydrochloride (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Anti-Diarrheal Agents
               Alosetron
                D02829  Alosetron hydrochloride (USAN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00046  Alosetron
                D02829  Alosetron hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00046  Alosetron
                D02829  Alosetron hydrochloride
              DG01642  CYP2C9 substrate
               DG00046  Alosetron
                D02829  Alosetron hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00046  Alosetron
                 D02829  Alosetron hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Serotonin
                HTR3
                 D02829  Alosetron hydrochloride (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02829
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02829
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02829
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00046  Alosetron
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00046  Alosetron
              DG01642  CYP2C9 substrate
               DG00046  Alosetron
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00046  Alosetron
DBLINKS     CAS: 122852-69-1
            PubChem: 17396986
            ChEBI: 53783
            LigandBox: D02829
ATOM        23
            1   X   Cl   32.7879  -18.6713
            2   C1x C    24.0510  -17.3425
            3   N1y N    24.0510  -18.7409
            4   C5x C    25.2620  -19.4401
            5   C8y C    26.4731  -18.7409
            6   C8y C    26.4731  -17.3425
            7   C1x C    25.2620  -16.6433
            8   O5x O    25.2620  -20.8383
            9   C8y C    27.8031  -19.1730
            10  C8y C    28.6250  -18.0417
            11  N4y N    27.8031  -16.9104
            12  C8x C    28.3718  -20.4505
            13  C8x C    29.7625  -20.5966
            14  C8x C    30.5845  -19.4653
            15  C8x C    30.0157  -18.1878
            16  C1b C    22.8400  -19.4401
            17  C8y C    21.6459  -18.7505
            18  C1a C    28.2337  -15.5851
            19  C8y C    21.6459  -17.3601
            20  C1a C    22.8464  -16.6669
            21  N4x N    20.3236  -16.9304
            22  C8x C    19.5063  -18.0552
            23  N5x N    20.3235  -19.1801
BOND        25
            1     2   3 1
            2     3   4 1
            3     4   5 1
            4     5   6 2
            5     6   7 1
            6     2   7 1
            7     4   8 2
            8     5   9 1
            9     9  10 1
            10   10  11 1
            11    6  11 1
            12    9  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   10  15 2
            17    3  16 1
            18   16  17 1
            19   11  18 1
            20   17  19 2
            21   19  20 1
            22   19  21 1
            23   21  22 1
            24   22  23 2
            25   17  23 1
///
